The event has been approved by the Royal College of Pathologists (RCPath) for 25 CPD credits for both in person and online participants and accredited by the Royal Society of Biology (RSB) for 93 CPD credits for only in person participants.
Overview
The Federation of Infection Societies (FIS) conference is the largest UK-hosted, international infection conference. It is a must-attend event for anyone working in infection prevention and control, infectious diseases, clinical microbiology and biomedical science.
This year, the Microbiology Society will be hosting FIS and will be partnering with the Healthcare Infection Society (HIS) and the British Infection Association (BIA) to develop the programme. The three-day, extensive programme will include a comprehensive number of sessions, plenary lectures, debates, clinical cases and networking opportunities. Join us on 14–15 November in Edinburgh and one day for an online meeting on 17 November.
Further information will be announced in the build up to the meeting on our social media channels. Follow us on Twitter @MicrobioSoc using the hashtag #FIS23 and on Instagram to stay up to date.
Image credit: PPrat
Programme
Session View
Tuesday 14 November, Morning
ACB: Diagnosis and management of difficult infections in haematology/oncology patients
-
Chair(s): Naomi Gadsby (Royal Infirmary of Edinburgh, UK)
-
Diagnosis and management of fungal infections in haematology/oncology patients
-
The Challenge of Multi-Drug Resistant Gram negatives in Haematology/Oncology & Transplant
-
Diagnosis and Management of viral infections in haematology/oncology patients
BSAC: Developing the Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS)
-
Chair(s): David Jenkins (University Hospitals of Leicester NHS Trust & BSAC President, UK)
-
The British Society for Antimicrobial Chemotherapy (BSAC) Global Antimicrobial Stewardship Accreditation Scheme - background
-
GAMSAS experience to date from BSAC team and plans for future spread
-
Assessor perspective
-
GAMSAS process at The Walton Centre NHS Foundation Trust
-
GAMSAS in an Irish hospital
NITCAR: Collaborative Research Projects
-
Chair(s): Ashleigh Hale and Katie Drury (Leeds Teaching Hospital, UK)
-
Introduction to NITCAR
-
Part 1: NITCAR updates
-
Introducing JOINTCASE
-
SALVAGE study
-
SINKBUG study
-
A Perpetual Observational Study for Acute Respiratory Infections (POS-ARI-ER): A New Approach to a Persistent Threat
-
Part 2: New approaches to collaborative research projects
-
POS-VAP: A flexible European infrastructure to facilitate implementation of trials on Ventilator Associated Pneumonia
-
Discussion
Tuesday 14 November, Afternoon
BSMM: The application of next generation sequencing in medical mycology
-
Chair(s): Malcolm Richardson (President of the British Society for Medical Mycology, UK)
-
Introduction
-
The Use of NGS in mycology
-
Use of NGS in routine diagnostics including for fungi
-
Unveiling the fungal mystery: genomic insights into Aspergillus fumigatus in clinical and environmental epidemiology
-
Q&A
UKHSA: National incident response – optimising clinical and public management of group A streptococcal infections and diphtheria
-
Chair(s): Mariyam Mirfenderesky (UK Health Security Agency, UK)
-
UKHSA national incident response: clinical and public health challenges of diphtheria control in the asylum seeking population
-
Public health response to surge in group A Streptococcus (GAS) disease in England, 2022
-
Introspect, innovate, inspire: new strategies needed to mitigate future surges in Group A Streptococcus (GAS) disease in England
BIA: Update on Management of Staph aureus bacteraemia
-
Chair(s): Anna Goodman (University College London & Guy's and St Thomas' NHS Foundation Trust, UK) and Patrick Lillie (Hull University Teaching Hospitals, UK)
-
Early oral switch in S. aureus bloodstream infection – is it reasonable?
-
Preventing healthcare Staphylococcus aureus blood stream infections
-
The role of 18F-FDG-PET/CT in Staphylococcus aureus bacteraemia
UKHSA: What next for AMR? The 2024-2029 UK Antimicrobial Resistance National Action Plan
-
Chair(s): Mariyam Mirfenderesky (UK Health Security Agency, UK) and Richard Puleston (UK Health Security Agency, UK)
-
Tackling AMR as a whole system approach - the UKHSA contribution to the UK AMR National Action Plan: past, present and future
-
The ups and downs of ambitions and targets within the UK NAP
-
Addressing health inequalities across work programmes of the UK Health Security Agency's Healthcare Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Usage & Sepsis Division
-
Learning from a review of international National Action Plans
Wednesday 15 November, Morning
BIA: Neurosurgical Infections
-
Chair(s): Fiona McGill (Leeds Teaching Hospitals NHS Trust, UK) and Susan Larkin (Liverpool University Hospitals Foundation Trust, UK)
-
Challenges in management of brain abscess
-
Challenges in management of multi-resistant gram negatives in neurosurgical infections
-
EVD Infections and an Infection Reduction Programme
Microbiology Society: AMR (translational research in the laboratory)
-
Chair(s): Tina Joshi (University of Plymouth, UK)
-
What can be learnt from a career understanding the complexities and diverse life-styles of Gram-negative Burkholderia bacteria?
-
The Path of Yeast Resistance - The rise of antifungal drug resistance
-
Investigating antibiotic access, use, and stewardship through an intersectional lens
UKCVN: Using vaccines to combat antimicrobial resistance
-
Chair(s): Ruth Payne (Sheffield Teaching Hospitals and University of Sheffield, UK) and Tom Darton (University of Sheffield, UK)
-
Unlocking the full public health value of vaccines: measuring the impact of vaccine on antimicrobial resistance
-
Vaccinating against antimicrobial resistance: pneumococcus and PCV
-
Vaccinating against antimicrobial resistance: Klebsiella pneumoniae, a priority pathogen
Wednesday 15 November, Afternoon
Free Papers 1
-
“The Mould that Changed the World”; Impact of a novel musical about Antimicrobial Resistance and Antibiotic Stewardship on audiences in the USA
-
Beta-lactam/beta-lactamase inhibitor combination resistant Enterobacterales invasive infection – outcomes of cephalosporin versus non-cephalosporin treatment options
-
Exclusion and empowerment: Experiences of living with Antimicrobial Resistance in the UK
-
Evaluation of Clinical Utility of FebriDx® In a UK A&E Department
-
Using Artificial Intelligence and Machine Learning to improve the management of patients with infections by actively involving clinical Microbiologists and infection specialists in the care of all patients through targeted, intelligent insights and interventions
-
Multi-drug resistant Corynebacterium diphtheriae in asylum seekers in England in 2022: an emerging public health concern
Free Papers 2
-
Educational effectiveness of a high-consequence infectious disease training course using ultraviolet simulation
-
Point of care ultrasound (POCUS) for the diagnosis of Botfly myiasis
-
An Outbreak of Cutaneous Leishmaniasis from Belize: Clinical, Diagnostic and Therapeutic Factors
-
Translating metagenomics into clinical practice of complex paediatric neurological presentations
-
Linezolid and antidepressants – what if co-prescribing was permitted?
-
Opportunities for Simulation Based Learning in Infection Medicine
Free Papers 3
-
Preventable Deaths involving Sepsis in England and Wales, 2013-2022: A Systematic Case Series of Coroners’ Reports
-
Understanding barriers and enablers for vaccination against COVID-19 and Influenza amongst healthcare workers in the SIREN Study
-
Disproportionate infection, hospitalisation, and death from COVID-19 in ethnic minority groups and Indigenous Peoples: an application of the Priority Public Health Conditions analytical framework
-
Human challenge using nasal Neisseria lactamica inoculation in pregnancy results in maternal but not infant N. lactamica colonisation and serological response
-
Investigating the winter burden of respiratory infections in UK healthcare workers: lessons from rapidly adapting the SIREN COVID-19 cohort study
Microbiology Society Infectious Disease Futures
-
Chair(s): Tina Joshi (University of Plymouth, UK) and Angharad Green (Healthcare Infection Society, UK)
-
Secrets of Tears: Host-pathogen Interactions in Ocular Chlamydia Infections
-
The impact of targeted molecular ciprofloxacin resistance testing on positive gonorrhoea samples in NHS Grampian
-
Inter-species interactions alter antimicrobial susceptibility in polymicrobial infection scenarios
-
The host signal bile modulates fungal-host interactions through transcriptional rewiring of virulence and metabolism
-
Implementation of a novel One Health approach to support the investigation of the largest Shiga-toxin producing E. coli (STEC) O157 outbreak in the UK since the introduction of Whole Genome Sequencing (WGS)
-
Emerging rhabdoviruses and human infection in Uganda
-
Increased numbers of patients with advanced alveolar echinococcosis presenting to a national referral centre
-
The elephant in the Salmonella room: an integrated approach identifies clade-specific signatures of invasive nontyphoidal Salmonella Enteritidis
BIA: Medical Education in Infection
-
Chair(s): Bethany Davies (Brighton and Sussex Medical School, UK) and Sylviane Defres (University of Liverpool, UK)
-
Update on undergraduate teaching and learning for infection specialists
-
Update on postgraduate training in infection specialities
-
The GermBugs: Stories and illustrations to teach medical microbiology
-
Strategies to promote active infection learning through gamification
-
The UK’s Première Infectious Diseases Podcast: 2 years of ID:IOTS
-
Education in IPC – responding to changes in demand, widening access and improving flexibility
-
Simulation Training in High Consequence Infectious Diseases (HCID) - Improving Confidence in Risk Assessment and PPE
Lecture View
Tuesday 14 November, Morning
-
Registration (Strathblane Hall)
-
Welcome Remarks
-
Is personalised infection prevention achievable?
-
Oh the Places You’ll Go! – a research journey in IPC
-
Coffee Break (Lennox Suite)
-
Diagnosis and management of fungal infections in haematology/oncology patients
-
Disseminated Gonococcal Infection in England
-
BPAIIG: Paediatric interactive cases
-
The British Society for Antimicrobial Chemotherapy (BSAC) Global Antimicrobial Stewardship Accreditation Scheme - background
-
Decontamination of Phacoemulsification Handpieces
-
Introduction to NITCAR
-
Part 1: NITCAR updates
-
Introducing JOINTCASE
-
SALVAGE study
-
GAMSAS experience to date from BSAC team and plans for future spread
-
SINKBUG study
-
The Challenge of Multi-Drug Resistant Gram negatives in Haematology/Oncology & Transplant
-
Tackling the rising incidence of Sexually Transmitted Infections in the United Kingdom
-
Assessor perspective
-
A Perpetual Observational Study for Acute Respiratory Infections (POS-ARI-ER): A New Approach to a Persistent Threat
-
Part 2: New approaches to collaborative research projects
-
GAMSAS process at The Walton Centre NHS Foundation Trust
-
Decontamination of Medical Devices in Healthcare
-
Diagnosis and Management of viral infections in haematology/oncology patients
-
Building a national STI reference laboratory to deliver molecular AMR surveillance
-
GAMSAS in an Irish hospital
-
POS-VAP: A flexible European infrastructure to facilitate implementation of trials on Ventilator Associated Pneumonia
-
Discussion
-
Lunch + Exhibition (Lennox Suite)
-
Introduction to publishing and the Microbiology Society, HIS and BIA journals
-
Journal Editor panel Q&A
Tuesday 14 November, Afternoon
-
Lunch + Exhibition (Lennox Suite)
-
Journal Editor panel Q&A
-
Keynote talk: Pathology networks: The Journey so far
-
Introduction
-
Introduction
-
The other side of the coin: what we know and what we need to know on selection of resistance and use of disinfectants
-
The pro debate
-
The con debate
-
UKHSA national incident response: clinical and public health challenges of diphtheria control in the asylum seeking population
-
The return of an old foe
-
The Use of NGS in mycology
-
Rash Decisions’
-
Public health response to surge in group A Streptococcus (GAS) disease in England, 2022
-
Use of NGS in routine diagnostics including for fungi
-
Disinfectants for the hospital environment; when to use or not to use?
-
Experience of the Midlands 1 Microbiology advanced network approach
-
To Be or Not To Be
-
Unveiling the fungal mystery: genomic insights into Aspergillus fumigatus in clinical and environmental epidemiology
-
Introspect, innovate, inspire: new strategies needed to mitigate future surges in Group A Streptococcus (GAS) disease in England
-
The unexpected tenant
-
Discussion
-
Panel Q&A
-
Q&A
-
Comfort break
-
Early oral switch in S. aureus bloodstream infection – is it reasonable?
-
Management of brain abscesses in children
-
Against
-
For
-
PPE choice and implementation
-
Tackling AMR as a whole system approach - the UKHSA contribution to the UK AMR National Action Plan: past, present and future
-
The ups and downs of ambitions and targets within the UK NAP
-
Preventing healthcare Staphylococcus aureus blood stream infections
-
Update on Invasive Fungal Diseases in Paediatrics
-
Safeguarding Infection Prevention & Control (IPC) before, during and after a pandemic
-
Addressing health inequalities across work programmes of the UK Health Security Agency's Healthcare Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Usage & Sepsis Division
-
The role of 18F-FDG-PET/CT in Staphylococcus aureus bacteraemia
-
Advocating for paediatric AMS in the UK
-
Joint Q&A
-
Learning from a review of international National Action Plans
-
Clinical rabies encephalomyelitis: diagnosis, management and vaccine prophylaxis
-
Poster Session + Exhibition (Lennox Suite)
-
Lowbury Social (Cromdale Hall)
Wednesday 15 November, Morning
-
Registration (Strathblane Hall)
-
The future of infection prevention and control: a dream to become real
-
Coffee Break (Lennox Suite)
-
Panel
-
Panel
-
Panel
-
Challenges in management of brain abscess
-
What can be learnt from a career understanding the complexities and diverse life-styles of Gram-negative Burkholderia bacteria?
-
Pandemic Preparedness – moving upstream in detection
-
Paediatric respiratory infections hit the GAS: what went wrong in 2022-3?
-
Driving IVOS at a national level - A Scottish perspective
-
Unlocking the full public health value of vaccines: measuring the impact of vaccine on antimicrobial resistance
-
The Path of Yeast Resistance - The rise of antifungal drug resistance
-
Surveillance for variants of SARS-CoV-2 and monkeypox virus to inform risk evaluation
-
Understanding lineage emergence in pathogenic streptococci
-
Driving IV to Oral Switch (IVOS) at a Local Level
-
Vaccinating against antimicrobial resistance: pneumococcus and PCV
-
Challenges in management of multi-resistant gram negatives in neurosurgical infections
-
Investigating antibiotic access, use, and stewardship through an intersectional lens
-
Outbreak research: successes, failures, and looking to the future
-
Streptococcus dysgalactiae – just one small Strep for mankind?
-
A critical appraisal of IV to oral antibiotic switch in practice
-
Vaccinating against antimicrobial resistance: Klebsiella pneumoniae, a priority pathogen
-
EVD Infections and an Infection Reduction Programme
-
Lunch + Exhibition (Lennox Suite)
-
Pfizer-sponsored promotional symposium: Personal Best: Top tips for antifungal stewardship
-
"What I wish I’d known as a new consultant"
-
Roundtable networking and problem discussions
Wednesday 15 November, Afternoon
-
Inflammation in infection: should we target the IL-6/CRP axis, and can genetics help us?
-
Comfort Break
-
“The Mould that Changed the World”; Impact of a novel musical about Antimicrobial Resistance and Antibiotic Stewardship on audiences in the USA
-
Educational effectiveness of a high-consequence infectious disease training course using ultraviolet simulation
-
Preventable Deaths involving Sepsis in England and Wales, 2013-2022: A Systematic Case Series of Coroners’ Reports
-
Secrets of Tears: Host-pathogen Interactions in Ocular Chlamydia Infections
-
Pfizer-sponsored promotional symposium: CPE = Challenging Pathogen Encounters
-
The impact of targeted molecular ciprofloxacin resistance testing on positive gonorrhoea samples in NHS Grampian
-
Beta-lactam/beta-lactamase inhibitor combination resistant Enterobacterales invasive infection – outcomes of cephalosporin versus non-cephalosporin treatment options
-
Point of care ultrasound (POCUS) for the diagnosis of Botfly myiasis
-
Understanding barriers and enablers for vaccination against COVID-19 and Influenza amongst healthcare workers in the SIREN Study
-
Inter-species interactions alter antimicrobial susceptibility in polymicrobial infection scenarios
-
Exclusion and empowerment: Experiences of living with Antimicrobial Resistance in the UK
-
An Outbreak of Cutaneous Leishmaniasis from Belize: Clinical, Diagnostic and Therapeutic Factors
-
Disproportionate infection, hospitalisation, and death from COVID-19 in ethnic minority groups and Indigenous Peoples: an application of the Priority Public Health Conditions analytical framework
-
The host signal bile modulates fungal-host interactions through transcriptional rewiring of virulence and metabolism
-
Implementation of a novel One Health approach to support the investigation of the largest Shiga-toxin producing E. coli (STEC) O157 outbreak in the UK since the introduction of Whole Genome Sequencing (WGS)
-
Evaluation of Clinical Utility of FebriDx® In a UK A&E Department
-
Translating metagenomics into clinical practice of complex paediatric neurological presentations
-
Human challenge using nasal Neisseria lactamica inoculation in pregnancy results in maternal but not infant N. lactamica colonisation and serological response
-
Emerging rhabdoviruses and human infection in Uganda
-
Using Artificial Intelligence and Machine Learning to improve the management of patients with infections by actively involving clinical Microbiologists and infection specialists in the care of all patients through targeted, intelligent insights and interventions
-
Linezolid and antidepressants – what if co-prescribing was permitted?
-
Investigating the winter burden of respiratory infections in UK healthcare workers: lessons from rapidly adapting the SIREN COVID-19 cohort study
-
Increased numbers of patients with advanced alveolar echinococcosis presenting to a national referral centre
-
The elephant in the Salmonella room: an integrated approach identifies clade-specific signatures of invasive nontyphoidal Salmonella Enteritidis
-
Multi-drug resistant Corynebacterium diphtheriae in asylum seekers in England in 2022: an emerging public health concern
-
Opportunities for Simulation Based Learning in Infection Medicine
-
Comfort Break
-
Update on undergraduate teaching and learning for infection specialists
-
Ocular Tuberculosis
-
Using genomics to optimise IPC
-
Point of Care and Community Diagnostics: The Patient Perspective and Experience
-
Clinical interactive case
-
U=U: unintentional undetectable?
-
Update on postgraduate training in infection specialities
-
The GermBugs: Stories and illustrations to teach medical microbiology
-
Candida Endopthalmitis and the role of routine opthalmological review in candidaemia
-
Surveillance frameworks and data essential in predicting patients’ risk of HCAI and AMR
-
Using Technology to Enhance Environmental Hygiene Monitoring
-
Anaerobic bacteraemia and cancer
-
It's all in your in head - Tackling neuroinflammatory differential diagnoses
-
Strategies to promote active infection learning through gamification
-
The UK’s Première Infectious Diseases Podcast: 2 years of ID:IOTS
-
Microbial keratitis from diagnosis to targeted treatment
-
Challenges and big questions in moving towards real-time integrated surveillance for AMR
-
AMR Diagnostics: Changing hearts and mindsets
-
Bacteroides fragilis enterotoxin; not so important in infection but a problem in the gut?
-
Escaping diagnosis – an elusive case of rapidly progressive encephalitis
-
Education in IPC – responding to changes in demand, widening access and improving flexibility
-
Simulation Training in High Consequence Infectious Diseases (HCID) - Improving Confidence in Risk Assessment and PPE
Exhibition & Sponsorship
FIS 2023 Exhibition and Sponsorship Pack
FIS 2023: Exhibition Hall Floorplan
FIS2023 is a unique event offering companies the opportunity to network and connect with a targeted group of individuals tailored for your products and services. This event is a unique collaboration of societies across the UK with interests in different aspects of Infectious Diseases and is a great opportunity to showcase your latest products, connect with key contacts and generate business leads. This year, FIS2023 will take place in-person and online, providing a great opportunity to expand your network, and increase your visibility and reach.
Exhibiting at this event will offer you the unique opportunity to interact with Infectious Disease and Clinical Microbiology specialists, Biomedical Scientists, Infection Control Nurses, Basic Scientists and Pharmacists all under one roof. FIS2023 is being held at the Edinburgh International Conference Centre (EICC) and over three days will see a programme packed with sessions covering the most important current issues facing infectious disease control, prevention, diagnosis and treatment.
There are packages to suit varying budgets and promotional requirements, please download our invitation to exhibit for more details. If you have any questions about the packages available please email [email protected].
FIS 2023 Exhibition and Sponsorship Pack
FIS 2023: Exhibition Hall Floorplan
Registration
Registration for FIS 2023 is now closed.
If you are a member of one of the following societies you are entitled to select the Member rates:
- Association for Clinical Biochemistry and Laboratory Medicine (ACB)
- British Infection Association (BIA)
- British Association for Sexual Health and HIV (BASHH)
- British Paediatric Allergy, Immunology & Infection Group (BPAIIG)
- British Society for Medical Mycology (BSMM)
- British Society for Antimicrobial Chemotherapy (BSAC)
- Central Sterilising Club (CSC)
- ESCMID Study Group for Nosocomial Infections (ESGNI)
- Healthcare Infection Society (HIS)
- Microbiology Society
- National Infection Teams Collaborative for Audit and Research (NITCAR)
- Scottish Microbiology Association (SMA)
- Society for Anaerobic Microbiology
- UK Clinical Vaccine Network (UK CVN)
- UK Clinical Pharmacy Association (UKCPA)
- UK Health Security Agency (UKHSA)
- Welsh Microbiology Association
If you are a member of a FIS participating society and registering for the event, you will be asked for the membership number of your society when you arrive at the event.
| Name | Full price |
| Member of FIS Participating Societies - 14 November & 15 November (in-person) | £504 |
| Member of FIS Participating Societies - 14 November only (in-person) | £252 |
| Member of FIS Participating Societies - 15 November only (in-person) | £252 |
| Member of FIS Participating Societies - 17 November Virtual Day Delegate Only and On Demand Content | £140 |
| Member of FIS Participating Societies - Full Conference (14 & 15 November in-person & 17 November virtual day) | £612 |
| Non Member - 14 November & 15 November (in-person) | £576 |
| Non Member - 14 November only (in-person) | £288 |
| Non Member - 15 November only (in-person) | £288 |
| Non Member - 17 November Virtual Day Delegate Only and On Demand Content | £156 |
| Non Member - Full Conference (14 & 15 November in-person & 17 November virtual day) | £708 |
| Student - 14 November & 15 November (in-person) | £274 |
| Student - 14 November only (in-person) | £138 |
| Student - 15 November only (in-person) | £138 |
| Student - 17 November Virtual Day Delegate Only and On Demand Content | £80 |
| Student - Full Conference (14 & 15 November in-person & 17 November virtual day) | £314 |
| Trainee / Pharmacist / Nurse - Member of FIS Participating Societies - 14 November & 15 November (in-person) | £352 |
| Trainee / Pharmacist / Nurse - Member of FIS Participating Societies - 14 November only (in-person) | £176 |
| Trainee / Pharmacist / Nurse - Member of FIS Participating Societies - 15 November only (in-person) | £176 |
| Trainee / Pharmacist / Nurse - Member of FIS Participating Societies - 17 November Virtual Day Delegate Only and On Demand Content | £108 |
| Trainee / Pharmacist / Nurse - Member of FIS Participating Societies - Full Conference (14 & 15 November in-person & 17 November virtual day) | £457 |
| Trainee / Pharmacist / Nurse - Non Member - 14 November only (in-person) | £215 |
| Trainee / Pharmacist / Nurse - Non Member - 15 November only (in-person) | £215 |
| Trainee / Pharmacist / Nurse - Non Member - 17 November Virtual Day Delegate Only and On Demand Content | £130 |
| Trainee / Pharmacist / Nurse - Non Member - Full Conference (14 & 15 November in-person & 17 November virtual day) | £545 |
| Trainee / Pharmacist / Nurse - Non-member - 14 November & 15 November (in-person) | £429 |
| Employee/representative of a commercial organisation - 14 November & 15 November (in-person) | £672 |
| Employee/representative of a commercial organisation - 14 November only (in-person) | £336 |
| Employee/representative of a commercial organisation - 15 November only (in-person) | £336 |
| Employee/representative of a commercial organisation - 17 November Virtual Day Delegate Only and On Demand Content | £204 |
| Employee/representative of a commercial organisation - Full Conference (14 & 15 November in-person & 17 November virtual day) | £852 |
Registration confirmation
Upon registration, you should receive an automated confirmation email. Please contact [email protected] if this has not been received within 24 hours.
Visa applications
If you need a letter of invitation for a visa application, we will be happy to supply this after we have received full payment. To find out if you need a visa to visit the UK, please visit the UK visa and immigration website.
Please note that all conference delegates are responsible for their own travel and visa arrangements; the Microbiology Society will not take any responsibility for travel or visa problems.
Payment information
All registration fees must be paid in full before arrival at the conference. Any outstanding registration fees must be paid before admittance will be granted to the conference.
Cancellations
Refunds are not provided; however, substitutions of attendees can be made at any time by contacting [email protected].
Abstracts and Posters
FIS 2023 Poster Abstract Book
FIS 2023 Poster Abstract Book
Abstract submission is now closed.
Abstracts are welcome for any of the following topics:
- Antimicrobial agents
- Antimicrobial resistance
- Antimicrobial stewardship
- Clinical cases
- Clinical Microbiology
- Collaboration and networks
- Decontamination
- Diagnostics
- Education and training
- Environment
- Fungal infections
- General
- Healthcare-associated infection
- Immunisation
- Innovation and knowledge mobilisation in IPC
- Outbreaks
- Outpatient Antibiotic Therapy
- Pathogenesis
- Quality improvement
- Research priorities
- Response to the COVID-19 pandemic
- Surgical site infections
- Surveillance and epidemiology
- Sustainability in healthcareTropical infections
- Viral infections
Abstracts should be submitted through the Oxford Abstracts system. Both members and non-members of the Microbiology Society are welcome to submit an abstract. Once submissions are closed, these will be reviewed by session Chairs and scientific committee members and you will be informed of the outcome directly. By submitting an abstract to this conference, you are indicating to the session organisers your commitment to attend the event.
Abstract Guidance
Abstracts should be a maximum of 250 words.
Please note that the abstract is the only information session organisers use when deciding whether to accept your work for presentation as an offered oral or poster. If accepted, it will be published in the online programme or poster abstract book for the conference – so think carefully about what needs to be included.
Oral presentations
In order to ensure your presentation runs smoothly, you are asked to comply with the following:
- PC versions of PowerPoint presentations are brought to the conference on a USB memory stick.
- Mac versions of PowerPoint presentations can only be accepted if you bring your own laptop and connecting cables.
- Please allow for Q&A time within your allocated speaking slot.
Posters
Those who are presenting a poster must ensure the work is presented as below. We cannot accommodate incorrectly formatted posters during the conference.
- Poster Size: A0 size 841mm(w) x 1189mm(h) – your poster should not exceed these measurements.
- Poster layout should be portrait orientation.
- Posters can be affixed with Velcro (provided at the conference).
- Your poster number will be sent prior to the conference.
Grants and Prizes
There are three prizes offered for submitted abstracts during the FIS International Conference 2023:
Journal of Medical Microbiology poster prize
Journal of Medical Microbiology will be offering two prizes to the posters that present particularly compelling or novel research in the fields of medical, dental and veterinary microbiology, and infectious diseases. We welcome everything from laboratory research to clinical trials, including bacteriology, virology, mycology and parasitology. The winners will receive a cash prize and certificate, and will be encouraged to submit their research to the Journal of Medical Microbiology.
Eligibility: All abstracts will be considered for the Journal of Medical Microbiology poster prize.
IPIP poster prize
Infection Prevention in Practice (IPIP) is the gold open access journal of the Healthcare Infection Society, and provides a comprehensive fully open access resource for all those working in the field of prevention and treatment of healthcare-associated infections worldwide. The editors of IPIP will award a prize to three posters submitted to the FIS 2023 conference. The winners will be invited to submit an article to IPIP based on the poster, and open access fees will be fully waived for articles which are published. The IPIP Editorial Team will support and assist the winners with the submission of their article.
During FIS 2023 IPIP editors will look out for high-quality posters likely to translate to articles in the field of infection prevention and control that will influence clinical best practice and reduce the global burden of infection in healthcare.
Eligibility: All abstracts will be considered for the IPIP poster prize.
Infectious Disease Futures and Infection Science Award
The Microbiology Society Infection Science Award is an exchange scheme that facilitates the most promising trainee and early career presenters from FIS to present at the Microbiology Society Annual Conference Infection Forum in an effort to improve the exchange of ideas and the career development of early career researchers and trainee scientists and doctors.
Eligibility: All self-defining early career and trainee presenters are eligible for the scheme. As a guide, the Microbiology Society’s ECM Forum considers you an early career microbiologist if you’re an undergraduate or postgraduate student, or within five years of appointment to your first position after your highest degree earned. However, if this doesn’t fit your situation and you consider yourself an early career researcher, you are welcome to join.
Entrants are required to be a member of a FIS organising society.
Selection of awardees
A judging panel will attend the session to judge the shortlisted entrants and select the awardees for announcement in the weeks following FIS 2023. The judges will focus on scientific content and communication and criteria related to the translation potential of research outlined in presentations.
Award amount
The awardees will be offered a fixed bursary to attend the Microbiology Society Annual Conference 2024 and invited to submit a short publication to Access Microbiology.
Entering the competition
You should indicate during abstract submission if you are eligible and wish to be entered for the Infection Science Award.
*FIS organising societies include: the British Infection Association (BIA), Healthcare Infection Society (HIS), and Microbiology Society.
Bursaries for virtual attendees from LMIC
Attendees from LMIC countries can apply for a bursary to cover the costs of the registration fee for virtual attendance only (17 November Virtual Day Delegate Only and On-Demand Content). LMIC attendees must submit their bursary application via email by 28 August 2023.
Applicants must permanently reside in a LMIC (as classified by the World Bank) and provide the following via email to [email protected]
- A letter from their employer supervisor on headed paper supporting their application
- The application must be sent from an institutional email address (email addresses such as gmail or hotmail are not acceptable)
All applicants will be informed of the outcome of their application by 11 September 2023 (23:59 BST) and will then be provided with a special code to allow FREE LMIC registration.
Grants for FIS hosting and FIS participating society members
Microbiology Society conference grants
Society Conference Grants will be available to support eligible Microbiology Society members presenting work at FIS23. Applications will open on 14 August 2023 and will close on 28 Aug (23:59 BST). Further information is available on the Society Conference Grant page.
Please contact [email protected] if you have any questions.
Healthcare Infection Society (HIS) member travel grants
HIS will offer travel grants of up to £750 to support the attendance of members who are presenting their Infection Prevention and Control (IPC) work at FIS 2023.
Applicants should apply for a HIS travel grant as soon they have confirmation that their abstract has been accepted. The deadline for receipt of travel grant applications is Monday 4 September 2023 12:00 pm BST. All applicants will be informed of the outcome of their application by Friday 8 September 2023.
Funding may be used to cover the registration fee, travel, accommodation and/or childcare costs.
Only members of HIS can apply. Eligibility commences immediately upon joining the Society and non-members can join the Society online.
Travel grants will preferentially be awarded to students, trainees, pharmacists, and nurses and are allocated according to pre-determined criteria which include:
- if the applicant has had an abstract accepted for an oral or poster presentation at the conference to present their IPC work (applicants must provide proof of abstract acceptance)
- the potential benefit to the applicant from attending the conference
- if the applicant has difficulty obtaining funding to attend FIS 2023 or has difficulty covering the costs of childcare
For further information and to apply for a HIS Travel Grant, follow this link to the website.
British Infection Association member travel grants
Travel grants are assessed on 31 January, 31 May, 31 October each year. Travel grants may be awarded retroactively if the timing of the conference or abstract notifications have not aligned with these deadlines
Apply for a British Infection Society Travel grant
Registering to attend FIS 2023
Microbiology Society and Healthcare Infection Society (HIS) applicants should await the outcome of your grant or bursary application before registering for the conference. The early bird registration deadline is 18 September 2023 (23:59). British Infection Association member travel grants will be awarded retroactively.
You must register to attend the conference yourself and claim back the registration fee from the Society which has awarded your grant.
Those who are attending from a LMIC using a bursary under option 1 above will be provided with a code to enable them to register. Only approved bursary applicants will be able to attend with the FREE LMIC registration.
Microbiology Society Infection Science Award
The Microbiology Society Infection Science Award is an exchange scheme that facilitates the most promising trainee and early career presenters from FIS to present at the Microbiology Society Annual Conference Infection Forum in an effort to improve the exchange of ideas and the career development of early career researchers and trainee scientists and doctors.
Eligibility
All self-defining early career and trainee presenters who hold membership in a FIS organising society* are eligible for the scheme. As a guide, the Microbiology Society’s ECM Forum considers you an early career microbiologist if you’re an undergraduate or postgraduate student, or within five years of appointment to your first position after your highest degree is earned. However, if this doesn’t fit your situation and you consider yourself an early career researcher, you are welcome to join.
*FIS organising societies include the British Infection Association (BIA), Healthcare Infection Society (HIS), and Microbiology Society.
To enter the competition, submit your abstract to the Infectious Disease Futures session and provide an additional statement about how the award will benefit your professional development.
Selection of awardees
A judging panel will attend the session to judge the entrants and select the awardees for an announcement in the weeks following FIS 2023. The judges will focus on scientific content and communication and will criteria related to the translation potential of research outlined in presentations.
Award amount
The awardees will be invited to speak in the Infection Forum at Microbiology Society Annual Conference 2024 and will be offered a fixed bursary to attend.
Destination and Accommodation
The conference will take place at the Edinburgh International Conference Centre (EICC):
150 Morrison Street,
Edinburgh,
EH3 8EE
Directions
By car
If you are travelling using a sat nav, please use the postcode EH3 8EE. The main entrance is 150 Morrison Street.
By air
The Airlink 100 operates a frequent bus service (every 10 minutes at peak times) between Edinburgh Airport and the city centre, with designated stops en route. The service starts at 04:30 and runs until 00:22 at night, with the journey taking 20 minutes. Tickets cost £4.50 for a single and £7.50 for a return. Delegates are advised to disembark at Haymarket Railway Station and to follow signs for EICC on foot (a 5-minute walk).
The N22 bus also departs from outside the Airport entrance and runs every half an hour through the night until the Airlink service starts again. For more information about these services visit www.flybybus.com.
By Tram
Edinburgh Trams run between the Airport and York Place every 8-10 minutes Monday to Saturday and every 12-15 minutes on Sundays. The closest tram stop to the EICC is at Haymarket Station. Please visit the Edinburgh Trams website for more details.
By rail
Edinburgh has two railway stations:
Waverley Station, which is 1.3 miles from EICC, is the city's main railway station and has direct routes to many cities across the country, including over 25 daily departures from London.
Haymarket Station, which is just 0.4 miles from EICC, is a stop for many commuters and some UK train routes. Please ensure that you check with your rail network provider to find out if your train will stop at Haymarket or Waverley.
By bus
Edinburgh's main bus terminal is located at St Andrew's Square. Visit Lothian Buses for more information on local bus services.
Coach
For information about travel by coach please visit the National Express website.
Car parking
There are many car parks within close walking distance of the EICC. Please see the EICC website for more details.
Accommodation
To support you in securing your accommodation we provide links to our booking and accommodation services via Reservation Highway.
Helpdesk: +44 (0) 1423 525577
Email: [email protected]
Reservation Highway has secured negotiated rates at hotels to suit a broad range of budgets.
Crèche
How to register for a Creche place at FIS 2023
The Society is again teaming up with Nipperbout to provide a free crèche at FIS 2023. The crèche will be available to all children of delegates between the ages of 0 and 12 years.
All registered delegates will be offered the opportunity to make use of these free childcare services, which will be offered on a first-come, first-served basis.
How to register your child
How to register for a Creche place at FIS 2023
In order to register, visit the Nipperbout portal.
Existing account holders who have already used the system can log into their existing account and register for the event using the event code: FIS141123 under Events and Sessions.
Members who have not used the system before can create an account by clicking register, completing the form and entering the event code: FIS141123. You will then be able to request a place for your child in the creche and create your password.
Booking is on a first-come, first-served basis. Confirmation of your booking will be sent prior to the conference.
Please note that you are entering into an agreement with Nipperbout and not the Microbiology Society.
Nipperbout is an award-winning event childcare company with over 25 years of experience. For more information, please visit the Nipperbout website. If you have any queries about this service, please contact: [email protected].
For further information, please contact: [email protected].